PedAM
Pediatric Disease Annotations & Medicines
| Disease | graves disease |
| Symptom | C0040156|thyrotoxicosis |
| Sentences | 20 |
| PubMedID- 21914308 | Initially, 12 of the 15 patients with thyrotoxicosis symptoms were misdiagnosed with grave's disease. |
| PubMedID- 23776932 | Therefore, patients with marine–lenhart syndrome can have thyrotoxicosis due to the graves disease as well as the nodule, which may be hyperfunctioning at the outset or may develop autonomicity after a variable period of time. |
| PubMedID- 21845211 | Resistant thyrotoxicosis in a patient with graves disease: a case report. |
| PubMedID- 25654065 | Effects of short-term potassium iodide treatment for thyrotoxicosis due to graves disease in children and adolescents. |
| PubMedID- 20868289 | Patients and medthods: in the present study, we report, for the first time, the concentrations of thyroid hormones, their carrier proteins, and thyroid antibodies in the pleural effusion of two thyrotoxicosis patients with graves' disease. |
| PubMedID- 19912243 | Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to graves' disease. |
| PubMedID- 23146624 | Patients and methods: the study involved 15 patients (4 men), mean age 51.8+/-15.3 years, mean bmi value - 24.7+/-3.5, with thyrotoxicosis due to graves' disease or toxic multinodular goitre. |
| PubMedID- 25838951 | Thyroid storm is a rare complication of thyrotoxicosis, most often associated with graves' disease. |
| PubMedID- 23193417 | Inclusion criteria:age 20–55;established thyrotoxicosis associated with graves' disease at the primary examination;consent of patient for participation in this study;the high quality of echocg images was required for better evaluation of heart structure and function. |
| PubMedID- 26425054 | We report a 35-yr-old man with thyrotoxicosis, ultimately attributed to graves' disease in whom antithyroid drug used initially was soon discontinued, due to abnormal liver function, and replaced by lugol's solution. |
| PubMedID- 22148004 | Typically, ifn-α-induced graves' disease patients present with symptomatic thyrotoxicosis and do not go into remission upon completion or cessation of ifn-α therapy. |
| PubMedID- 21188237 | Thyroid abnormalities, especially hypothyroidism and thyrotoxicosis due to graves' disease or hashitoxicosis, as well as insulin dependent diabetes mellitus (t1dm) were dominant autoimmune disorders. |
| PubMedID- 20713346 | Objective: to describe a patient who, 5 years after total thyroidectomy to treat graves disease, presented with thyrotoxicosis due to nonmalignant lateral ectopic thyroid tissue. |
| PubMedID- 26484334 | Some years after this diagnosis, the patient presented thyrotoxicosis due to grave's disease and the thrombocytopenia relapsed, but this time there was no response to the glucocorticoids. |
| PubMedID- 24566408 | Lower incidence of postpartum thyrotoxicosis in women with graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs. |
| PubMedID- 24526195 | Pulmonary hypertension in a pregnant patient with thyrotoxicosis due to graves' disease: considerations with respect to treatment. |
| PubMedID- 25878906 | She also had thyrotoxicosis due to graves' disease. |
| PubMedID- 23762777 | Antithyroid drugs are the mainstay of the treatment of postpartum thyrotoxicosis due to graves' disease . |
| PubMedID- 26181502 | Pericarditis is a rare presentation of thyrotoxicosis associated with graves disease. |
| PubMedID- 20467360 | The majority of patients present in middle age with concurrent thyrotoxicosis due to graves' disease. |
Page: 1